← All stories
Markets
BioNTech (BNTX) to Unveil Lung Cancer Trial Results at WCLC 2026, Featuring First Pumitamig Plus ADC Combo Data
BioNTech SE (Nasdaq: BNTX) announced it will showcase new clinical findings from its lung cancer pipeline at the IASLC 2026 World Conference on Lung Cancer in Seoul, South Korea, scheduled for 12–15 September 2026. The presentations will hi…
Covered by 1 outlet
All coverage · 1 article